Alexandra Crook

Alexandra Crook

Auto-generated profile, based on publicly available information

Alexandra Crook

Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz, Aurora, Colorado

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Journal of Virology
Verified
Journal Article
Open access
BSBikash Ranjan Sahoo
Bikash Ranjan Sahoo
ACAlexandra A. Crook
Alexandra A. Crook
APAryamav Pattnaik
Aryamav Pattnaik
ATAlondra D. Torres-Gerena
Alondra D. Torres-Gerena
Oleh KhalimonchukOleh Khalimonchuk
Oleh Khalimonchuk
Asit PattnaikAsit Pattnaik
Asit Pattnaik
Zika virus (ZIKV) is a major public health concern of international proportions. While the incidence of ZIKV infections has declined substantially in recent years, the potential for the reemergence or reintroduction remains high.

7 July 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ACAlexandra Crook
Alexandra Crook
ALAline Leite
Aline Leite
TPThomas Payne
Thomas Payne
FBFatema Bhinderwala
Fatema Bhinderwala
JWJade Woods
Jade Woods
Robert PowersRobert Powers
Robert Powers
Exposure to acute, damaging radiation may occur through a variety of events from cancer therapy and industrial accidents to terrorist attacks and military actions. Our understanding of how to protect individuals and mitigate the effects of radiation injury or Acute Radiation Syndrome (ARS) is still limited. There are only a few Food and Drug Administration-approved therapies for ARS; whereas, amifostine is limited to treating low dose (0.7–6 Gy) radiation poisoning arising from cancer radiotherapy. An early intervention is critical to treat ARS, which necessitates identifying diagnostic biomarkers to quickly characterize radiation exposure. Towards this end, a multiplatform metabolomics study was performed to comprehensively characterize the temporal changes in metabolite levels from mice and non-human primate serum samples following γ-irradiation. The metabolomic signature of amifostine was also evaluated in mice as a model for radioprotection. The NMR and mass spectrometry metabolomics analysis identified 23 dysregulated pathways resulting from the radiation exposure. These metabolomic alterations exhibited distinct trajectories within glucose metabolism, phospholipid biosynthesis, and nucleotide metabolism. A return to baseline levels with amifostine treatment occurred for these pathways within a week of radiation exposure. Together, our data suggests a unique physiological change that is independent of radiation dose or species. Furthermore, a metabolic signature of radioprotection was observed through the use of amifostine prophylaxis of ARS.

3 September 2026
Verified
Other
Open access
PDF file
SPSweta B. Patel
Sweta B. Patel
DMDaniel R. Moskop
Daniel R. Moskop
SMSteven Moreira
Steven Moreira
SGStephanie Gipson
Stephanie Gipson
CAColin C. Anderson
Colin C. Anderson
EPEric M Pietras
Eric M Pietras
HR-MDS HSPCs have a distinct metabolic profile compared to healthy control HSPCs.

3 September 2026
Verified
Other
Open access
SPSweta B. Patel
Sweta B. Patel
DMDaniel R. Moskop
Daniel R. Moskop
SMSteven Moreira
Steven Moreira
SGStephanie Gipson
Stephanie Gipson
CAColin C. Anderson
Colin C. Anderson
EPEric M Pietras
Eric M Pietras
Geneset Enrichment Analysis for microarray data (GSE19429) comparing differentially expressed genes in HR-MDS (N=183) versus healthy control (N=17) CD34+ HSPCs.

3 September 2026
Verified
Other
Open access
SPSweta B. Patel
Sweta B. Patel
DMDaniel R. Moskop
Daniel R. Moskop
SMSteven Moreira
Steven Moreira
SGStephanie Gipson
Stephanie Gipson
CAColin C. Anderson
Colin C. Anderson
EPEric M Pietras
Eric M Pietras
Nitrogen flux metabolomic data obtained using UHPLC/MS from MDS-L cell line treated with DMSO or 100nM OT-82 for 24h and supplemented with 2mM 15N2-Tryptophan for the full 24h.

3 September 2026
Verified
Other
Open access
SPSweta B. Patel
Sweta B. Patel
DMDaniel R. Moskop
Daniel R. Moskop
SMSteven Moreira
Steven Moreira
SGStephanie Gipson
Stephanie Gipson
CAColin C. Anderson
Colin C. Anderson
EPEric M Pietras
Eric M Pietras
PLS-DA loadings from UHPLC/MS-based global metabolomic analysis data of MDS-L cell line treated with DMSO or 100nM OT-82 for 24h.